Citations

Clear

585 citation(s) found for "Tran, W".

Skimmed breast milk for treatment of hypertriglyceridemia in an infant with congenital nephrotic syndrome
Dahl, Amanda , Armellino, A., Tran, Cheryl L. , Tebben, Peter J. , Dahl, Amanda R , Armellino, Andrea L, Tebben, Peter

Mayo Clinic

Nutrition in Clinical Practice | September 6, 2021 | Volume: 37 | Issue: 2 | Pages: 383-387

10.1002/ncp.10759 | PMID 34486165 Get It

AbstractCongenital nephrotic syndrome (CNS) is a complex condition that requires multidisciplinary care. Hyperlipidemia is a characteristic feature with elevation of serum cholesterol and triglycerides. Little evidence is available to guide treatment of dyslipidemia in infants with CNS. We describe successful treatment of severe hypertriglyceridemia through dietary changes in a boy with CNS. A 9‐day‐old boy presented to the emergency department with lower extremity edema caused by deep venous thrombosis. Laboratory evaluation identified hypoalbuminemia, nephrotic‐range proteinuria, and a pathogenic variant of the NPHS1 gene. The initial triglyceride concentration of 369 mg/dl increased to 3096 mg/dl by 5 weeks of age, when his diet consisted of breast milk. Refrigerated breast milk was skimmed by removing the top layer after allowing it to separate for 24 h. This process was repeated prior to use. Skimmed breast milk was supplemented with medium‐chain triglyceride oil and an infant protein powder. After 2 days, the triglyceride concentration declined to 481 mg/dl and, by day 10, to 148 mg/dl. When breast milk supply decreased, a 1:1 ratio of skimmed maternal breast milk to an elemental, very low‐fat formula was utilized. The triglyceride concentration remained below 400 mg/dl for the first year of life, except when skimmed breast milk was not available during hospitalization. Severe hypertriglyceridemia caused by CNS can present in the neonatal period and be difficult to manage. In our patient, skimmed maternal breast milk was successful in reducing the triglyceride concentration and should be considered a therapeutic option for children with hyperlipidemia caused by CNS.
Psychometric Evaluation of the Kansas City Cardiomyopathy Questionnaire in Men and Women With Heart Failure
Hejjaji, Vittal , Coles, Theresa , Jones, Philip G. , Reeve, Bryce B. , Mentz, Robert J. , Spatz, Erica S. , Caldwell, Brittany, Saha, Anindita , Tarver, Michelle E. , Tran, Andy T , Patel, Krishna , Henke, Debra M. , Spertus, John A. , Coles, Theresa , Jones, Philip G , Reeve, Bryce B. , Spatz, Erica S , Dunlay, Shannon M. , Saha, Anindita , Patel, Krishna K , Spertus, John A , Mentz, Robert J , Tang, Yuanyuan , Piña, Ileana L.

Mayo Clinic

Circulation: Heart Failure | September 1, 2021 | Volume: 14 | Issue: 9 | Pages: No page available

10.1161/circheartfailure.120.008284 | PMID 34465123 Get It

Background: The Kansas City Cardiomyopathy Questionnaire (KCCQ) has been psychometrically evaluated in multiple heart failure (HF) populations, but the comparability of its psychometric properties between men and women is unknown. Methods: Data from 3 clinical trials (1 in stable HF with preserved ejection fraction, 1 each in stable and acute HF with reduced ejection fraction) and 1 prospective cohort study (stable HF with reduced ejection fraction), incorporating 6773 men and 3612 women with HF, were used to compare the construct validity, internal and test-retest reliability, ability to detect change, predict mortality and hospitalizations and minimally important differences between the 2 sexes. Interactions of the KCCQ overall summary and subdomain scores by sex were independently examined. Results: The KCCQ-Overall Summary score correlated well with New York Heart Association functional class in both sexes across patients with stable (correlation coefficient: −0.40 in men versus −0.49 in women) and acute (−0.37 in men versus −0.34 in women) HF. All KCCQ subdomains demonstrated concordant relationships with relevant comparison standards with no significant interactions by sex in 19 of 21 of these construct validity analyses. All KCCQ scores were equally predictive and other psychometric evaluations showed similar results by sex: test-retest reliability (intraclass correlation coefficient 0.94 in men versus 0.92 in women), responsive to change (standardized response mean 1.01 in both sexes), as were the minimally important differences and internal reliability. Conclusions: The psychometric properties of the KCCQ, in terms of validity, prognosis, reliability, and sensitivity to change, are comparable in men and women with HF with preserved ejection fraction and HF with reduced ejection fraction.
A Pilot Study of Ponatinib in Patients With FGFR-Altered Advanced Cholangiocarcinoma
Ahn, Daniel H. , Usón, Pedro Luiz Serrano , Masci, Peter, Mody, Kabir , DeLeon, Thomas, Gores, Gregory, Smoot, Rory L. , Bekaii‐Saab, Tanios , Mansfield, Aaron, Smoot, Rory L , Uson, Pedro L S , Bekaii-Saab, Tanios S , Kosiorek, Heidi , Hálfdánarson, Þorvarður R. , Babiker, Hani M. , Sonbol, Mohamad Bassam , Mahipal, Amit , Tran, Nguyen H. , Hubbard, Joleen M. , Borad, Mitesh J.

Mayo Clinic

No container title available | July 29, 2021 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.21203/rs.3.rs-741191/v1 Get It

Abstract Background:Biliary tract cancers (BTC) are rare, chemo resistant and are associated with a poor prognosis. Preclinical and early clinical work had demonstrated interesting anti-tumor activity from targeting fibroblast growth factor receptor (FGFR) pathway. We hypothesized that ponatinib, a multi-targeted tyrosine kinase inhibitor with activity against FGFR, would be active in BTC patients with FGFR alterations.Methods:This was a multi-center, single institution pilot study of ponatinib in patients with advanced, refractory BTC with FGFR alterations. The primary end point was overall response rate, with secondary points of overall survival (OS), progression-free survival (PFS) and Health Related Quality of Life (HRQoL) assessment. Results:Twelve patients were enrolled prior to early termination of the trial. Clinical benefit (defined as complete/partial response + stable disease) of 45.5% was observed. All observed toxicities were manageable and reversible. Toxicities were mild, with lymphopenia (75%), rash (63%) and fatigue (50%) being the most frequent. No significant detriment in global QoL was observed.Conclusions:Ponatinib as a single agent in FGFR altered BTC is tolerable with very modest clinical activity. This is the first report of prospective assessment of FGFR inhibition in BTC using ponatinib, and the first study to report its effect on HRQoL. Further development of ponatinib will involve correlative studies to better refine patient selection, focus on combinations with other molecular targeted agents, conventional cytotoxic chemotherapy, and studies to better understand mechanisms of treatment resistance.
FGFR Inhibitor Toxicity and Efficacy in Cholangiocarcinoma: Multicenter Single-Institution Cohort Experience
Gile, Jennifer , Ou, Fang‐Shu , Mahipal, Amit , Larson, Joseph J. , Mody, Kabir , Jin, Zhaohui , Hubbard, Joleen M. , Hálfdánarson, Þorvarður R. , Alberts, Steven R. , Jatoi, Aminah , Smoot, Rory L. , Roberts, Lewis R. , Bekaii‐Saab, Tanios , Gile, Jennifer Jane , Hubbard, Joleen , Halfdanarson, Thorvardur R , McWilliams, Robert R , Ma, Wen Wee , Ilyas, Sumera, Roberts, Lewis R , Borad, Mitesh J , Smoot, Rory L , Mahipal, Amit , Alberts, Steven R , Ou, Fang-Shu , Bekaii-Saab, Tanios S , Jin, Zhaohui , McWilliams, Robert R. , Wee, Wen , Ilyas, Sumera I. , Gores, Gregory J. , Borad, Mitesh J. , Tran, Nguyen H.

Mayo Clinic

JCO Precision Oncology | July 28, 2021 | Volume: No volume available | Issue: 5 | Pages: 1228-1240

10.1200/po.21.00064 | PMID 34778691 Get It

PURPOSECholangiocarcinomas (CCA) are a group of heterogeneous tumors arising from the biliary epithelia. Significant sequencing efforts have provided further insights into the molecular mechanisms of this disease including fibroblast growth factor receptor ( FGFR) alterations, which occurs in approximately 15%-20% of intrahepatic CCAs. Herein, we describe the FGFR inhibitor (FGFRi)-associated treatment toxicity and cancer-specific outcomes from a multicenter single-institution cohort.METHODSThis is a retrospective study of patients with CCA and known FGFR alterations treated with FGFRi. We describe the toxicity and efficacy in patients treated at Mayo Clinic between January 2010 and December 2020.RESULTSOur group identified 61 patients with advanced or metastatic CCA, 19 males (31%) and 42 females (69%), harboring FGFR alterations who received FGFRi. The most common grade 1 or higher adverse events for all patients included fatigue (92%), AST elevations (78%), anemia (80%), decreased platelet count (63%), and hyperphosphatemia (74%). Median progression-free survival on FGFRi was 5.8 months for all patients (95% CI, 4.9 to 9.0). Females had significantly longer progression-free survival at 6.9 months (95% CI, 5.2 to 11.8) on FGFRi compared with males at 4.9 months (95% CI, 2.8 to not estimable; P = .038).CONCLUSIONFGFRi are well tolerated with clinical efficacy. With the recent approval of FGFRi by the US Food and Drug Administration and ongoing clinical trials for new FGFRi, understanding outcomes and toxicity associated with these medications is important for precision oncology.
Association of gastric emptying with postprandial appetite and satiety sensations in obesity
Gonzalez‐Izundegui, Daniel, Campos, Alejandro , Ricardo-Silgado, Maria Laura , Cifuentes, Lizeth , Decker, Paul A. , Tran, Linh , Burton, Duane, Dayyeh, Barham Abu, Camilleri, Michael , Eckel‐Passow, Jeanette E. , Calderon, Gerardo, Ricardo-Silgado, Maria L, Abu Dayyeh, Barham, Camilleri, M , Acosta, Andres , Campos, Alejandro , Calderon-Lopez, Gerardo , Decker, Paul A. , Vargas, Eric J. , Acosta, Andrés

Mayo Clinic

Obesity | July 27, 2021 | Volume: 29 | Issue: 9 | Pages: 1497-1507

10.1002/oby.23204 | PMID 34313001 Get It

AbstractObjectiveSatiety, defined as the duration of the sensation of fullness, is usually measured by validated visual analog scales (VAS) for appetite. Gastric function plays a key role in food intake regulation. However, the association between gastric emptying (GE) and VAS appetite is unknown.MethodsIn this cross‐sectional study, 134 participants (mean [SEM] age = 39 [0.8] years, mean [SEM] BMI = 38 [0.5] kg/m2, 67% females) completed simultaneous measurements of GE and VAS appetite. After a 320‐kcal meal, GE was measured by scintigraphy and appetite by validated 100‐mm VAS for 240 minutes. Satiation was defined as calories consumed to terminate meal and was measured by an ad libitum meal. GE, VAS, and ad libitum meal tests were measured on the same day. Percent of meal retention in the stomach, VAS area under curve (AUC0‐240 min), and overall appetite score (OAS) were calculated. Pearson correlation (ρ) determined the association of GE with VAS appetite and satiation. Appetite components were also analyzed by quartiles based on GE120 min.ResultsGE120 min was correlated with sensation of VAS hungerAUC(0‐240 min) (ρ = 0.24, p = 0.004), fullnessAUC(0‐240 min) (ρ = 0.16, p = 0.05), and OASAUC(0‐240 min) (ρ = 0.20, p = 0.02). Patients with rapid GE120 min had a mean increase in VAS hungerAUC(0‐240 min) by 32 mm/min (15.62%, p = 0.03) compared with normal/slow GE120 min.ConclusionsGE is associated with the sensations of appetite, and rapid GE is associated with increased appetite, which may contribute to weight gain.
Double Frost Suture Technique for Simultaneous Skin Grafting of the Upper and Lower Eyelids
DeMaria, Lauren N., Tran, Ann Q. , Tooley, Andrea A. , North, Victoria S. , Flores, Roberto L. , Lisman, Richard D. , Belinsky, Irina

Mayo Clinic

Ophthalmic Plastic & Reconstructive Surgery | July 23, 2021 | Volume: 37 | Issue: 6 | Pages: e217-e221

10.1097/iop.0000000000002032 | PMID 34297708 Get It

The double Frost suture is a useful supplement to the reconstruction of ipsilateral upper and lower eyelid defects with full-thickness skin grafts. This technique involves silk traction sutures that overlap the upper and lower eyelids to place them on maximal stretch after placement of 2 full-thickness skin grafts. It has the added benefit of protecting the cornea and compressing both grafts under 1 bolster. The authors illustrate this technique in 2 pediatric cases—a congenital melanocytic kissing eyelid nevus and a periocular burn. Each case resulted in large upper and lower anterior lamellar defects, which were reconstructed with supraclavicular and retroauricular free skin grafts. The double Frost sutures counter vertical cicatricial forces during graft healing, obviating the need for staged procedures. Both described cases resulted in excellent graft survival with minimal contracture.
Ultrasound-Guided Diagnostic IPACK as a Valuable Tool in the Management of a Patient with Soleal Sling Syndrome: A Doubly Rare Case Report
Clendenen, Steven R. , Ferreira‐Dos‐Santos, Guilherme , Hurdle, Mark Friedrich B., Tran, John , Eldrige, Jason S. , Murray, Peter M. , B Hurdle, Mark Friedrich, Agur, Anne Maria Reet

Mayo Clinic

Pain Management | July 21, 2021 | Volume: 12 | Issue: 1 | Pages: 5-12

10.2217/pmt-2020-0104 | PMID 34284601 Get It

Occupational insecticide exposure and risk of non‐Hodgkin lymphoma: A pooled case‐control study from the InterLymph Consortium
Roos, Anneclaire J. De , Schinasi, Leah H. , Miligi, Lucia , Cerhan, James R. , Bhatti, Parveen , Baris, Dalsu , Benavente, Yolanda , Benke, Geza , Clavel, Jacqueline , Casabonne, Delphine, Monnereau, Alain , Vajdic, Claire M. , Wang, Sophia , Zhang, Yawei, Cocco, Pierluigi , De Roos, Anneclaire J , Vajdic, Claire M , Cerhan, James R , Cocco, Pierluigi , Wang, Sophia S , Bhatti, Parveen , Clavel, Jacqueline , Mannetje, Andrea ’t , Casabonne, Delphine , Fritschi, Lin , Hofmann, Jonathan N. , Huynh, Tran , Piro, Sara , Slager, Susan L. , Zhang, Yawei, Bernstein, Leslie

Mayo Clinic

International Journal of Cancer | July 16, 2021 | Volume: 149 | Issue: 10 | Pages: 1768-1786

10.1002/ijc.33740 | PMID 34270795 Get It

AbstractEvidence for the human health effects of pesticides is needed to inform risk assessment. We studied the relationship between occupational insecticide use and risk of non‐Hodgkin lymphoma (NHL) by pooling data from nine case‐control studies participating in the InterLymph Consortium, including 7909 cases and 8644 controls from North America, the European Union and Australia. Insecticide use was coded using self‐report or expert assessment, for insecticide groups (eg, organophosphates, pyrethroids) and active ingredients (eg, malathion, permethrin). Associations with insecticides were estimated using logistic regression to produce odds ratios (ORs) and 95% confidence intervals (CI) for all NHL and NHL subtypes, with adjustment for study site, demographic factors and use of other pesticides. Occupational insecticide use, overall, was not associated with risk of NHL. Use of organophosphate insecticides was associated with increased risk of all NHL and the subtype follicular lymphoma, and an association was found with diazinon, in particular (ever use: OR = 2.05, 95%CI: 1.24‐3.37). The carbamate insecticide, carbaryl, was associated with risk of all NHL, and the strongest associations were found with T‐cell NHL for ever‐use (OR = 2.44, 95%CI: 1.13‐5.28) and longer duration (>8 years vs never: OR = 2.90, 95%CI: 1.02‐8.25). There was no association of NHL with other broad groups of insecticides, including organochlorines and pyrethroids, and some inverse associations were estimated in relation to historical DDT use. Our findings contribute to the totality of evidence available to help inform risk decisions by public health and regulatory agencies of importance given continued, widespread use of organophosphate and carbamate insecticides.
Skeletal Muscle β‐F1‐ATPase Translation is Inhibited by Hyperlipidemia‐Induced miR‐127‐5p Expression in Human Obesity
Campbell, Latoya E., Mandarino, Lawrence J. , Tran, Lee, Coletta, Dawn K. , Katsanos, Christos S.

Mayo Clinic

The FASEB Journal | June 21, 2021 | Volume: 29 | Issue: S1 | Pages: No page available

10.1096/fasebj.29.1_supplement.974.6 Get It

We recently discovered persistent downregulation of the H + ‐ATP synthase catalytic subunit (β‐F1‐ATPase) in skeletal muscle of obese individuals, which was linked to comorbid hyperlipidemia. β‐F1‐ATPase expression is primarily regulated post‐transcription, i.e. miRNAs, but the precise mechanism impeding expression are unclear. We tested the hypothesis that hyperlipidemia reduces β‐F1‐ATPase translational efficiency and is mediated by miR‐127‐5p, a miRNA known to control β‐F1‐ATPase translation. Biopsies isolated from the vastus lateralis of lean (BMI蠄25; n=7) and obese (BMI蠅30; n=6) subjects were evaluated for mRNA/miRNA expression via qRT‐PCR, protein by Western blot, and translation efficiency was calculated as the mRNA/protein ratio. Our results confirmed β‐F1‐ATPase translation was lower in obese individuals (P<0.01; 0.25±0.05%) compared to healthy weight controls (0.59±0.09%), and correlated with miR‐127‐5p expression (P<0.01; r=‐0.67). Bisulfite sequencing analysis of the miR‐127‐5p promoter revealed two hypomethylated sites in obese individuals, which may sustain an upregulation. Moreover, we found miR‐127‐5p present in muscle‐derived blood exosomes suggesting putative involvement in intracellular cross‐talk. In primary myotubes from a lean volunteer, prolonged fatty acid exposure increased miR‐127‐5p expression. Free Fatty Acid (mEq/L) Unsaturated/ Saturated mRNA (2 ‐ DD Ct ) Protein (AU) Translation (%) CTRL 0.347 ‐ 1.70±0.113 0.216±0.062 0.130±0.040 Lo Fat 0.185 0.55 1.60±0.094 0.202±0.038 0.123±0.008 Hi Fat 0.251 2.29 1.35±0.133* 0.095±0.006* 0.073±0.010 Hi Fat 0.269 0.54 1.66±0.145 0.093±0.003* 0.050±0.004* * P <0.05; One‐way ANOVA, Tukey9s posttest Inhibiting miR‐127‐5p with locked nucleic acids dose‐dependently improved β‐F1‐ATPase translation. Inhibitor (nM) mRNA (2 ‐ DD Ct ) Protein (AU) Translation (%) 0 1.84±0.314 0.22±0.062 0.647±0.120 10 1.93±0.387 1.24±0.135* 0.500±0.148 50 2.00±0.498 1.24±0.242** 1.483±0.233* 100 1.76±0.207 1.54±0.086* 0.892±0.096 * P <0.05; ** P <0.01; *** P <0.001; 1‐way ANOVA, Tukey9s posttest Our results provide evidence implicating hyperlipidemia‐induced miR‐127‐5p expression in suppressing β‐F1‐ATPase translation in human obesity. Funding from NIH/NIDDK grant DK094062 to CSK